GEMMA BETH ANDERSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ARLINGTON, TX NPI 1124524780
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX PFIZER INC. All categories
General Payments — all program years on this page
$2,616.40
- Category: General Payments
- Program years: PY2021–2024
- Record count: 91
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,570.81 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,481.81 | 60 |
| Education | $89.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $187.23 | 8 |
| Merck Sharp & Dohme Corporation | $167.05 | 8 |
| Takeda Pharmaceuticals U.S.A., Inc. | $113.89 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $95.05 | 4 |
| ABBVIE INC. | $86.77 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $85.66 | 3 |
| Blueprint Medicines Corporation | $81.49 | 3 |
| EISAI INC. | $79.58 | 3 |
| Incyte Corporation | $70.79 | 3 |
| Janssen Biotech, Inc. | $63.93 | 3 |
| SOBI, INC | $63.20 | 2 |
| Daiichi Sankyo Inc. | $57.54 | 2 |
| Stemline Therapeutics Inc. | $45.75 | 2 |
| Myriad Genetic Laboratories, Inc. | $40.85 | 1 |
| PharmaEssentia USA Corporation | $34.88 | 1 |
| EMD Serono, Inc. | $33.23 | 1 |
| Karyopharm Therapeutics Inc. | $31.39 | 1 |
| Kite Pharma, Inc. | $27.93 | 1 |
| Exelixis Inc. | $25.54 | 1 |
| ADC Therapeutics America, Inc. | $24.92 | 1 |
| Acerta Pharma LLC | $24.16 | 1 |
| Adaptive Biotechnologies Corporation | $23.49 | 1 |
| Astellas Pharma US Inc | $23.47 | 1 |
| Genentech USA, Inc. | $22.53 | 1 |
| ARRAY BIOPHARMA INC | $22.15 | 1 |
| TAIHO ONCOLOGY, INC. | $19.35 | 1 |
| Immunocore Limited | $18.99 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.